Skip to main content
Log in

C-reactive protein gene polymorphisms affect plasma CRP and homocysteine concentrations in subjects with and without angiographically confirmed coronary artery disease

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Human C-reactive protein (CRP) is a reactant involved in the acute phase response and one of the many molecular factors involved in pathogenesis of coronary artery disease (CAD). CRP gene variants potentially mediate CRP plasma concentrations and the development of CAD. 220 Croatian subjects with angiographically confirmed CAD and 132 control subjects were included in the study. CRP gene polymorphisms 1059G/C and -717G/A were determined by RFLPs, using MaeIII and KspI endonuclease, respectively. Plasma concentrations of CRP and homocysteine were determined by immunoturbidimetry and FPIA, respectively. CRP 1059G/C gene variants were significantly associated with CAD (OR = 0.50; 95% CI = 0.27, 0.94; P = 0.032). Wild GG genotype and rare allele C carrier genotypes were 184 and 22 in CAD(+) group, and 101 and 24 in CAD(−) group, respectively. Multivariate analysis with age, gender, BMI, smoking status, hypertension and diabetes as covariates showed that 1059C carriers had lower CRP concentrations in CAD(−) (P = 0.010) and CAD(+) subjects (P = 0.028). This allele was also significantly associated with lower plasma homocysteine concentrations in both groups (P = 0.018 for CAD(−) and 0.002 for CAD(+). There was no significant difference between CAD(+) and CAD(−) subjects in absolute frequencies for CRP -717A/G gene variant, but multivariate analysis showed that carriers of the rarer G allele had significantly higher CRP plasma concentrations in CAD(−) subjects (P = 0.031) and higher homocysteine concentrations in CAD(+) group (P < 0.001). Atherosclerosis is an inflammatory disease resulting from different genetic and environmental factors. Results presented here support the contribution of CRP genetic variations in the development of CAD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

BMI:

Body mass index

CAD:

Coronary artery disease

CRP:

C-reactive protein

ICAM-1:

Intercellular adhesion molecule-1

IL:

Interleukin

HDL-C:

High density lipoprotein cholesterol

LDL-C:

Low density lipoprotein cholesterol

MI:

Myocardial infarction

MCP-1:

Monocyte chemoattractant molecule-1

NF-κB:

Nuclear factor kappaB

TNF-α:

Tumor necrosis factor-α

VCAM-1:

Vascular cell adhesion molecule-1

References

  1. Kushner I (1982) The phenomena of acute phase response. Ann NY Acad Sci USA 389:39–48

    Article  CAS  Google Scholar 

  2. de Ferranti S, Rifai N (2002) C-reactive protein and cardiovascular disease: a review of risk prediction and interventions. Clin Chim Acta 317:1–15

    Article  PubMed  Google Scholar 

  3. Li JJ, Fang CH (2004) C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases. Med Hypotheses 62:499–506

    Article  PubMed  CAS  Google Scholar 

  4. Ballou SP, Kushner I (1992) C-reactive protein and the acute phase response. Adv Intern Med 37:313–336

    PubMed  CAS  Google Scholar 

  5. Francisco G, Hernández C, Simó R (2006) Serum markers of vascular inflammation in dyslipemia. Clin Chim Acta 369:1–16

    Article  PubMed  CAS  Google Scholar 

  6. Danesh J, Wheeler JG, Hirschfield GM et al (2004) C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350:1387–1397

    Article  PubMed  CAS  Google Scholar 

  7. Ridker PM, Cannon CP, Morrow D et al (2005) Pravastatin or atorvastatin evaluation and infection therapy—thrombolysis in myocardial infarction 22 (PROVE IT-TIMI 22) investigators. C-reactive protein levels and outcomes after statin therapy. N Engl J Med 352:20–28

    Article  PubMed  CAS  Google Scholar 

  8. NCBI OMIM database (2008) Johns Hopkins University. http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=123260. Cited 2 Jan 2008

  9. Kovacs A, Green F, Hansson LO et al (2005) A novel common single nucleotide polymorphism in the promoter region of the C-reactive protein gene associated with the plasma concentration of C-reactive protein. Atherosclerosis 178:193–198

    Article  PubMed  CAS  Google Scholar 

  10. Brull DJ, Serrano N, Zito F et al (2003) Human CRP gene polymorphism influences CRP levels: implications for the prediction and pathogenesis of coronary heart disease. Arterioscler Thromb Vasc Biol 23:2063–2069

    Article  PubMed  CAS  Google Scholar 

  11. Lange LA, Carlson CS, Hindorff LA et al (2006) Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events. JAMA 296:2703–2711

    Article  PubMed  CAS  Google Scholar 

  12. Crawford DC, Sanders CL, Qin X et al (2006) Genetic variation is associated with C-reactive protein levels in the Third National Health and Nutrition Examination Survey. Circulation 114:2458–2465

    Article  PubMed  CAS  Google Scholar 

  13. Pasceri V, Willerson JT, Yeh ET (2000) Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102:2165–2168

    PubMed  CAS  Google Scholar 

  14. Pasceri V, Cheng JS, Willerson JT, Yeh ET (2001) Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation 103:2531–2534

    PubMed  CAS  Google Scholar 

  15. Wang G, Siow YL, O K (2000) Homocysteine stimulates nuclear factor kappaB activity and monocyte chemoattractant protein-1 expression in vascular smooth-muscle cells: a possible role for protein kinase C. Biochem J 352 Pt 3:817–826

    Article  PubMed  CAS  Google Scholar 

  16. Hattori Y, Matsumura M, Kasai K (2003) Vascular smooth muscle cell activation by C-reactive protein. Cardiovasc Res 58:186–195

    Article  PubMed  CAS  Google Scholar 

  17. Wang G, Siow YL, O K (2001) Homocysteine induces monocyte chemoattractant protein-1 expression by activating NF-kappaB in THP-1 macrophages. Am J Physiol Heart Circ Physiol 280:H2840–H2847

    PubMed  CAS  Google Scholar 

  18. Cao H, Hegele RA (2000) Human C-reactive protein (CRP) 1059G/C polymorphism. J Hum Genet 45:100–101

    Article  PubMed  CAS  Google Scholar 

  19. Suk HJ, Ridker PM, Cook NR, Zee RY (2005) Relation of polymorphism within the C-reactive protein gene and plasma CRP levels. Atherosclerosis 178:139–145

    Article  PubMed  CAS  Google Scholar 

  20. Araujo F, Pereira AC, Mota GF, Latorre Mdo R, Krieger JE, Mansur AJ (2004) The influence of tumor necrosis factor-308 and C-reactive protein G1059C gene variants on serum concentration of C-reactive protein: evidence for an age-dependent association. Clin Chim Acta 349:129–134

    Article  PubMed  CAS  Google Scholar 

  21. Zee RY, Hegener HH, Fernandez-Cruz A, Lindpaintner K (2004) C-reactive protein gene polymorphisms and the incidence of post-angioplasty restenosis. Atherosclerosis 176:393–396

    Article  PubMed  CAS  Google Scholar 

  22. Suk Danik J, Chasman DI, Cannon CP et al (2006) Influence of genetic variation in the C-reactive protein gene on the inflammatory response during and after acute coronary ischemia. Ann Hum Genet 70:705–716

    Article  PubMed  CAS  Google Scholar 

  23. Eklund C, Lehtimaki T, Hurme M (2005) Epistatic effect of C-reactive protein (CRP) single nucleotide polymorphism (SNP) +1059 and interleukin-1B SNP +3954 on CRP concentration in healthy male blood donors. Int J Immunogenet 32:229–232

    PubMed  CAS  Google Scholar 

  24. Chen J, Zhao J, Huang J, Su S, Qiang B, Gu D (2005) -717A>G polymorphism of human C-reactive protein gene associated with coronary heart disease in ethnic Han Chinese: the Beijing atherosclerosis study. J Mol Med 83:72–78

    Article  PubMed  CAS  Google Scholar 

  25. Miller DT, Zee RY, Suk Danik J et al (2005) Association of common CRP gene variants with CRP levels and cardiovascular events. Ann Hum Genet 69:623–638

    Article  PubMed  CAS  Google Scholar 

  26. Ridker PM (2003) High-sensitivity C-reactive protein and cardiovascular risk: rationale for screening and primary prevention. Am J Cardiol 92(4B):17K–22K

    Article  PubMed  CAS  Google Scholar 

  27. Harrington JR (2000) The role of MCP-1 in atherosclerosis. Stem Cells 18:65–66

    Article  PubMed  CAS  Google Scholar 

  28. Hai CM (2007) Airway smooth muscle cell as therapeutic target of inflammation. Curr Med Chem 14:67–76

    Article  PubMed  CAS  Google Scholar 

  29. Girelli D, Martinelli N, Olivieri O et al (2006) Hyperhomocysteinemia and mortality after coronary artery bypass grafting. PLoS ONE 1:e83

    Article  PubMed  Google Scholar 

  30. Ramakrishnan S, Sulochana KN, Lakshmi S, Selvi R, Angayarkanni N (2006) Biochemistry of homocysteine in health and diseases. Indian J Biochem Biophys 43:275–283

    PubMed  CAS  Google Scholar 

  31. Li JJ, Fang CH, Chen MZ, Chen X, Lee SW (2004) Activation of nuclear factor-kappaB and correlation with elevated plasma C-reactive protein in patients with unstable angina. Heart Lung Circ 13:173–178

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This investigation was supported by Project Grants No. 108247 and 108-1080316-0298 of the Croatian Ministry of Science, Education and Sport.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Daria Pašalić.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pašalić, D., Marinković, N., Gršković, B. et al. C-reactive protein gene polymorphisms affect plasma CRP and homocysteine concentrations in subjects with and without angiographically confirmed coronary artery disease. Mol Biol Rep 36, 775–780 (2009). https://doi.org/10.1007/s11033-008-9244-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-008-9244-1

Keywords

Navigation